MK-0941
Code | Size | Price |
---|
TAR-T12057-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T12057-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
MK-0941 is an orally active and allosteric glucokinase activator, has potential in the treatment of type 2 diabetes.
CAS:
1137916-97-2
Formula:
C22H28N4O9S2
Molecular Weight:
556.61
Purity:
0.98
SMILES:
CS(O)(=O)=O.CCS(=O)(=O)c1ccc(Oc2cc(O[C@@H](C)CO)cc(c2)C(=O)Nc2ccn(C)n2)cn1
References
1. Eiki J, et al. Pharmacokinetic and pharmacodynamic properties of the glucokinase activator MK-0941 in rodent models of type 2 diabetes and healthy dogs. Mol Pharmacol. 2011 Dec;80(6):1156-65.